A 24 Week Open Label Study of the Utility of Adalimumab in Active Axial Forms of Psoriatic Arthritis

NCT00963313 · clinicaltrials.gov ↗
COMPLETED
Status
29
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Dr. FRANCISCO J. BLANCO-GARCIA